New to Meducation?
Sign up
Already signed up? Log In
view moderators

Therapeutics

Category

6
1
56

Individualizing First Line Therapy for Advanced NSCLC, by Dr. Suresh Ramalingam (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Suresh Ramalingam, medical oncologist and leader of the Thoracic Oncology Program at Emory University, reviews the evolution of first line treatment of advanced non-small cell lung cancer to our current tailored approach for optimal outcomes.</span></p>  
Howard (Jack) West, MD
almost 9 years ago
7
1
18

The Role of EGFR Inhibitor Therapy as Post-Operative Treatment for Early Stage NSCLC: A Controversial Question (audio)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Jared Weiss, medical oncologist from the Univ. of Pennsylvania, covers limited data and current clinical trials addressing potential role of EGFR inhibitors, and particularly Tarceva (erlotinib), as post-surgical treatment for advanced NSCLC.</span></p>  
Howard (Jack) West, MD
almost 9 years ago
8
1
26

The Role of EGFR Inhibitor Therapy as Post-Operative Treatment for Early Stage NSCLC: A Controversial Question (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Jared Weiss, medical oncologist from the Univ. of Pennsylvania, covers limited data and current clinical trials addressing potential role of EGFR inhibitors, and particularly Tarceva (erlotinib), as post-surgical treatment for advanced NSCLC.</span></p>  
Howard (Jack) West, MD
almost 9 years ago
9
1
58

Second Line Treatment of Adv NSCLC: What Drugs and When? (audio)

This slide presentation by Dr. Julie Brahmer, medical oncologist and lung cancer expert at Johns Hopkins University, reviews the factors to be considered in the selection of agents and timing of treatments given after first line therapy for advanced NSCLC.  
Howard (Jack) West, MD
almost 9 years ago
10
1
65

Second Line Treatment of Adv NSCLC: What Drugs and When? (video)

This slide presentation by Dr. Julie Brahmer, medical oncologist and lung cancer expert at Johns Hopkins University, reviews the factors to be considered in the selection of agents and timing of treatments given after first line therapy for advanced NSCLC.  
Howard (Jack) West, MD
almost 9 years ago
11
1
13

Individualizing Treatment for NSCLC Based on Molecular Factors (audio)

This slide presentation by Dr. George Simon, Director of Thoracic Oncology at Fox Chase Cancer Center, describes emerging molecular variables that are being studied to optimize individualized selection of systemic treatments for NSCLC.  
Howard (Jack) West, MD
almost 9 years ago
12
1
17

Individualizing Treatment for NSCLC Based on Molecular Factors (video)

This slide presentation by Dr. George Simon, Director of Thoracic Oncology at Fox Chase Cancer Center, describes emerging molecular variables that are being studied to optimize individualized selection of systemic treatments for NSCLC.  
Howard (Jack) West, MD
almost 9 years ago
13
1
36

Introduction to First Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (audio)

This slide presentation by Dr. Alan Sandler, medical oncologist and Division Chief of Hematology/Oncology at Oregon Health & Science University, provides an introduction to our current first line treatment options for metastatic NSCLC.  
Howard (Jack) West, MD
almost 9 years ago
0
1
30

Introduction to First Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (video)

This slide presentation by Dr. Alan Sandler, medical oncologist and Division Chief of Hematology/Oncology at Oregon Health & Science University, provides an introduction to our current first line treatment options for metastatic NSCLC.  
Howard (Jack) West, MD
almost 9 years ago
1
1
25

Treating Lung Cancer: Past, Present, and Future (Audio)

This slide presentation by Dr. Ramiswamy Govindan, medical oncologist at Washington University in St. Louis, offers a broad perspective on the history of treating cancer with chemotherapy, our current treatment approaches, and a preview of emerging technologies that are poised to become a more individualized way of treating cancer.  
Howard (Jack) West, MD
almost 9 years ago
2
2
24

Treating Lung Cancer: Past, Present, and Future (Video)

This slide presentation by Dr. Ramiswamy Govindan, medical oncologist at Washington University in St. Louis, offers a broad perspective on the history of treating cancer with chemotherapy, our current treatment approaches, and a preview of emerging technologies that are poised to become a more individualized way of treating cancer.  
Howard (Jack) West, MD
almost 9 years ago
7
1
19

Adjuvant (Post-Operative) Therapy for Resected Early Stage NSCLC (Video)

This slide presentation by Dr. Heather Wakelee, medical oncologist at Stanford University, describes the current evidence supporting post-operative treatment of resected non-small cell lung cancer (NSCLC) and leading trials in the field.  
Howard (Jack) West, MD
almost 9 years ago
8
1
23

Adjuvant (Post-Operative) Therapy for Resected Early Stage NSCLC (Audio)

This slide presentation by Dr. Heather Wakelee, medical oncologist at Stanford University, describes the current evidence supporting post-operative treatment of resected non-small cell lung cancer (NSCLC) and leading trials in the field.  
Howard (Jack) West, MD
almost 9 years ago
13
2
30

Current Questions and Clinical Trials in Post-Operative/Adjuvant Therapy for Early Stage NSCLC (Audio)

This slide presentation by Dr. Heather Wakelee, medical oncologist at Stanford University, describes the key clinical research issues being addressed in post-operative treatment of resected non-small cell lung cancer (NSCLC).  
Howard (Jack) West, MD
almost 9 years ago
0
1
21

Current Questions and Clinical Trials in Post-Operative/Adjuvant Therapy for Early Stage NSCLC (Video)

This slide presentation by Dr. Heather Wakelee, medical oncologist at Stanford University, describes the key clinical research issues being addressed in post-operative treatment of resected non-small cell lung cancer (NSCLC).  
Howard (Jack) West, MD
almost 9 years ago
1
2
27

Cancer Lifeline Lecture - Part 3, Locally Advanced, Unresectable NSCLC (Audio)

This slide presentation is part of a lecture by medical oncologist and lung cancer expert Dr. Jack West, in which he covers the optimal treatment strategies for locally advanced (stage III), unresectable NSCLC.  
Howard (Jack) West, MD
almost 9 years ago
2
1
12

Cancer Lifeline Lecture - Part 3, Locally Advanced, Unresectable NSCLC (Video)

This slide presentation is part of a lecture by medical oncologist and lung cancer expert Dr. Jack West, in which he covers the optimal treatment strategies for locally advanced (stage III), unresectable NSCLC.  
Howard (Jack) West, MD
almost 9 years ago
3
1
32

Interview with George Simon on Molecular Variables and Treatment Selection for NSCLC (Video)

Dr. George Simon, medical oncologist at Fox Chase Cancer Center in Philadelphia, discusses the current evidence and emerging treatment patterns related to molecular variables in treatment of NSCLC.  
Howard (Jack) West, MD
almost 9 years ago
4
1
32

Interview with George Simon on Molecular Variables and Treatment Selection for NSCLC (Audio)

Dr. George Simon, medical oncologist at Fox Chase Cancer Center in Philadelphia, discusses the current evidence and emerging treatment patterns related to molecular variables in treatment of NSCLC.  
Howard (Jack) West, MD
almost 9 years ago
7
1
25

Management Options for Stage IIIA NSCLC: The Outer Limits of Resectability (Audio)

This slide presentation by medical oncologist and lung cancer expert Dr. Jack West covers the most common management strategies for stage IIIA N2 node-positive NSCLC, with a particular focus on a comparison of preoperative treatment followed by surgery vs. chemo and radiation without surgery.  
Howard (Jack) West, MD
almost 9 years ago